about As a global biopharma company working to deliver enduring impact for patients and public health, we are always innovating to develop medicines that protect, improve and save lives around the world. Throughout our 110-year history, we've delivered many defining moments in Australian and global medical science. This includes producing Australia's first insulin, pioneering plasma fractionation, developing novel therapies for rare and serious diseases, expanding global influenza pandemic preparedness and advancing treatments that improve the lives of millions of people worldwide. Each breakthrough moment builds on the last, creating the expertise, scientific capability and global partnerships that position CSL to deliver the next generation of medical innovation and patient impact. CSL IMPACT REPORT 2026 | 3 CSL
RkJQdWJsaXNoZXIy MjE2NDg3